Lataa...
Inactivation of NF1 promotes resistance to EGFR inhibition in KRAS/NRAS/BRAF(V600)-wildtype colorectal cancer
Through the use of an unbiased, genome-scale CRISPR modifier screen, we identified NF1 suppression as a mechanism of resistance to EGFR inhibition in NRAS/KRAS/BRAF(V600)-wildtype colorectal cancer (CRC) cells. Reduced NF1 expression permitted sustained signalling through the MAPK (mitogen-activated...
Tallennettuna:
| Julkaisussa: | Mol Cancer Res |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7611272/ https://ncbi.nlm.nih.gov/pubmed/32098826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-19-1201 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|